BTI Distal Femoral Intramedullary Rod System
by Biodynamic Technologies, Inc.
510(k) K970897
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK970897 | Date21 Apr 1997 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- HSB
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3020
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The BTI Distal Femoral Intramedullary Rod System is an orthopedic intramedullary device designed for internal fixation of distal femoral fractures. It provides stable alignment and support to the bone during the healing process, facilitating proper skeletal restoration and weight-bearing functionality.
This system is supplied as a reusable surgical implant and has received FDA 510(k) clearance under the traditional review pathway, classified under product code HSB. It is intended for use in orthopedic procedures and is regulated as a Class II medical device. The system’s design adheres to orthopedic standards for intramedullary fixation, ensuring compatibility with standard surgical techniques and equipment.
Other devices from Biodynamic Technologies, Inc.
Questions
AI-generated answers, 19 Sep 2026
What types of distal femoral fractures is this intramedullary rod system designed to treat, and how does it support healing?
The BTI Distal Femoral Intramedullary Rod System is specifically designed for internal fixation of distal femoral fractures, providing stable alignment and structural support to the bone during the healing process. By maintaining proper skeletal alignment, it facilitates optimal bone restoration and helps restore weight-bearing functionality, which is critical for recovery and mobility.
Is this device reusable or single-use, and what does that mean for surgical planning?
The BTI Distal Femoral Intramedullary Rod System is supplied as a reusable surgical implant. This means it is intended to be used in multiple procedures after proper cleaning, sterilization, and inspection, reducing costs and waste compared to single-use devices. However, reuse requires strict adherence to manufacturer guidelines for reprocessing to ensure safety and efficacy.
What regulatory pathway was followed for FDA clearance, and how does that affect its classification?
The BTI Distal Femoral Intramedullary Rod System received FDA clearance under the traditional 510(k) review pathway, classified under product code HSB and regulated as a Class II medical device. This pathway involves a detailed comparison to a legally marketed predicate device, ensuring the system meets established safety and performance standards for orthopedic intramedullary fixation.
How does the system’s design ensure compatibility with standard orthopedic surgical techniques?
The system’s design adheres to orthopedic standards for intramedullary fixation, meaning it is engineered to integrate seamlessly with conventional surgical tools, techniques, and equipment. This ensures surgeons can use familiar approaches while benefiting from the rod’s stability and alignment support for distal femoral fractures.